The iPhone effect in healthcare: How Mounjaro is rewriting the economics of India’s pharma market
LiveMint

Like eager buyers queuing for the latest iPhone, urban Indians are chasing
next-generation weight-loss injections regardless of price. Eli Lilly’s
Mounjaro has dethroned long-time bestseller Augmentin, sparking an
unprecedented market boom for GLP-1 drugs.





